Press Release
Category Added in a WPeMatico Campaign
-
Business Wire1 week ago
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
Patients aged 60-75 treated with Orca-T and a reduced intensity conditioning regimen (RIC) experienced low incidence of acute and chronic…
Read More » -
Business Wire1 week ago
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in…
Read More » -
Business Wire1 week ago
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was…
Read More » -
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration…
Read More » -
MarketersMEDIA Newswire1 week ago
Midwest MSP Titans of the Industry Recognizes GoTech IT Solutions as 2025 Awards Finalist
GoTech IT Solutions has been named a finalist in the 2025 MSP Titans of the Industry Awards, a prestigious recognition…
Read More » -
Business Wire1 week ago
NMDP℠ Demonstrates Scientific Leadership in Expanding Patient Access to Lifesaving Cell Therapy at ASH 2025
New results from the Phase II ACCESS trial represent a significant milestone in solving one of transplant medicine’s biggest challenges:…
Read More » -
Advances in Technology Help Improve Safety and Access to Blood Cancer Therapies
Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patients ORLANDO, Fla., Dec. 6, 2025…
Read More » -
Business Wire1 week ago
ReAlta Announces Promising Phase 2 Data Demonstrating Rapid Clinical Responses and Target Engagement in Steroid-Refractory Acute GvHD at the ASH 2025 Annual Meeting
Pegtarazimod demonstrates significant clinical improvement and reduction in inflammatory markers in patients with lower gastrointestinal acute GvHD NORFOLK, Va.–(BUSINESS WIRE)–ReAlta…
Read More » -
Business Wire1 week ago
Genetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation
Data presented was selected for ASH’s exclusive program to highlight the most impactful research submitted for this year’s meeting Real-world…
Read More » -
Business Wire1 week ago
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
– Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta…
Read More »

